UV Disinfection Technology Combats Superbugs
|
By HospiMedica International staff writers Posted on 20 Jun 2013 |

Image: The TRU-D SmartUVC portable disinfection system (Photo courtesy of TRU-D).
An Ultraviolet C band (UVC) disinfection robot automatically calculates the pathogen-lethal UV dose needed to kill pathogens and disinfect a room.
The TRU-D SmartUVC portable disinfection system achieves high efficiency by automatically and consistently providing touchless UVC room disinfection, calculating the UVC light emission required for each room, dynamically compensating for room size, shape, and other dose-altering variables such as the position of contents, windows, blinds, and doors. Among the features of the system are dose assurance delivered to direct and shadowed high touch surfaces, rapid room disinfection, and environmental safety, since UVC light is not transmitted through glass windows.
The system technology is based on the fact that UV light near a wavelength of 254 nm induces the formation of pyrimidine dimmers from thymine and cytosine. These dimers in turn cause breaks in microbial DNA that make genetic replication impossible, thus destroying the organisms or rendering them unable to grow or reproduce. The efficacy of the UVC irradiation is a function of many different parameters, such as intensity, exposure time, lamp placement, and air movement patterns.
TRU-D thus automates the labor-intensive process of manual cleaning, providing cleaner rooms and faster turnover without human error and without using chemicals. The disinfection progress is displayed in real-time to ensure 3-4 log surface disinfection of pathogens in any space. Human error, such as missed surfaces, recontamination, and improper chemical applications, are eliminated. An added bonus is that rooms can be occupied immediately after treatment. The TRU-D SmartUVC portable disinfection robot is a product of TRU-D (Memphis, TN, USA).
Related Links:
TRU-D
The TRU-D SmartUVC portable disinfection system achieves high efficiency by automatically and consistently providing touchless UVC room disinfection, calculating the UVC light emission required for each room, dynamically compensating for room size, shape, and other dose-altering variables such as the position of contents, windows, blinds, and doors. Among the features of the system are dose assurance delivered to direct and shadowed high touch surfaces, rapid room disinfection, and environmental safety, since UVC light is not transmitted through glass windows.
The system technology is based on the fact that UV light near a wavelength of 254 nm induces the formation of pyrimidine dimmers from thymine and cytosine. These dimers in turn cause breaks in microbial DNA that make genetic replication impossible, thus destroying the organisms or rendering them unable to grow or reproduce. The efficacy of the UVC irradiation is a function of many different parameters, such as intensity, exposure time, lamp placement, and air movement patterns.
TRU-D thus automates the labor-intensive process of manual cleaning, providing cleaner rooms and faster turnover without human error and without using chemicals. The disinfection progress is displayed in real-time to ensure 3-4 log surface disinfection of pathogens in any space. Human error, such as missed surfaces, recontamination, and improper chemical applications, are eliminated. An added bonus is that rooms can be occupied immediately after treatment. The TRU-D SmartUVC portable disinfection robot is a product of TRU-D (Memphis, TN, USA).
Related Links:
TRU-D
Latest Critical Care News
- AI Stethoscope Spots Heart Valve Disease Earlier Than GPs
- Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
- Wearable Patch Provides Up-To-The-Minute Readouts of Medication Levels in Body
- New Spray-Mist Device Delivers Antibiotics Directly into Infected Tissue
- Living Implant Could End Daily Insulin Injections
- Intelligent Camera System Continuously Monitors Premature Babies in NICU
- Intranasal Spray to Prevent Illnesses from Respiratory Viruses
- Gut Bacteria from Amphibians and Reptiles Show Complete Tumor Elimination
- High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy
- AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
- Glowing Bacterial Sensors Could Improve Detection of Gut Illness
- Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

- New Nanomaterial Kills Cancer Cells While Sparring Healthy Tissues
- AI Model Accurately Predicts Neurological Recovery After Cardiac Arrest
- Battery-Free Nano-Sensors Pave Way for Next-Generation Wearables
- Imaging Technology Detects Early Signs of Cardiovascular Risk Through Skin
Channels
Artificial Intelligence
view channelSurgical Techniques
view channel
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read more
New Imaging Combo Offers Hope for High-Risk Heart Patients
Patients with type 2 diabetes often develop complex, severe coronary artery disease involving multiple narrowed or blocked arteries, making complete revascularization difficult. Without detailed functional... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







